
Anna Kathy Aman
Examiner (ID: 18092, Phone: (571)272-4515 , Office: P/2914 )
| Most Active Art Unit | 2914 |
| Art Unit(s) | 2914, 2973 |
| Total Applications | 3318 |
| Issued Applications | 3249 |
| Pending Applications | 17 |
| Abandoned Applications | 54 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8824834
[patent_doc_number] => 20130125879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-23
[patent_title] => 'MICROPARTICLE FORMULATION FOR PULMONARY DRUG DELIVERY OF ANTI INFECTIVE MOLECULE FOR TREATMENT OF INFECTIOUS DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/813470
[patent_app_country] => US
[patent_app_date] => 2011-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13861
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13813470
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/813470 | Microparticle formulation for pulmonary drug delivery of anti infective molecule for treatment of infectious diseases | Aug 3, 2011 | Issued |
Array
(
[id] => 8675466
[patent_doc_number] => 08383579
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-26
[patent_title] => 'Method for customized dispensing of variable dose drug combination products for individualizing of therapies'
[patent_app_type] => utility
[patent_app_number] => 13/197486
[patent_app_country] => US
[patent_app_date] => 2011-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 10611
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13197486
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/197486 | Method for customized dispensing of variable dose drug combination products for individualizing of therapies | Aug 2, 2011 | Issued |
Array
(
[id] => 8713358
[patent_doc_number] => 08399498
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-19
[patent_title] => 'Animal ectoparasite-controlling agent'
[patent_app_type] => utility
[patent_app_number] => 13/194300
[patent_app_country] => US
[patent_app_date] => 2011-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15008
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13194300
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/194300 | Animal ectoparasite-controlling agent | Jul 28, 2011 | Issued |
Array
(
[id] => 7818651
[patent_doc_number] => 20120065271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-15
[patent_title] => 'METHOD OF ACCELERATING MUSCLE GROWTH, DECREASING FAT DEPOSITS AND IMPROVING FEED EFFICIENCY IN LIVESTOCK ANIMALS'
[patent_app_type] => utility
[patent_app_number] => 13/185153
[patent_app_country] => US
[patent_app_date] => 2011-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17000
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20120065271.pdf
[firstpage_image] =>[orig_patent_app_number] => 13185153
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/185153 | METHOD OF ACCELERATING MUSCLE GROWTH, DECREASING FAT DEPOSITS AND IMPROVING FEED EFFICIENCY IN LIVESTOCK ANIMALS | Jul 17, 2011 | Abandoned |
Array
(
[id] => 8725584
[patent_doc_number] => 08404702
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-26
[patent_title] => 'Pharmaceutical formulations:salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same'
[patent_app_type] => utility
[patent_app_number] => 13/184926
[patent_app_country] => US
[patent_app_date] => 2011-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 5685
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13184926
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/184926 | Pharmaceutical formulations:salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same | Jul 17, 2011 | Issued |
Array
(
[id] => 8858668
[patent_doc_number] => 08461203
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-11
[patent_title] => 'Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy'
[patent_app_type] => utility
[patent_app_number] => 13/182324
[patent_app_country] => US
[patent_app_date] => 2011-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 28757
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13182324
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/182324 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy | Jul 12, 2011 | Issued |
Array
(
[id] => 8771942
[patent_doc_number] => 08425893
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-23
[patent_title] => 'Polyurethanes for osteoimplants'
[patent_app_type] => utility
[patent_app_number] => 13/181715
[patent_app_country] => US
[patent_app_date] => 2011-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10051
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13181715
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/181715 | Polyurethanes for osteoimplants | Jul 12, 2011 | Issued |
Array
(
[id] => 7511517
[patent_doc_number] => 20110257227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo Methylphenidate'
[patent_app_type] => utility
[patent_app_number] => 13/172977
[patent_app_country] => US
[patent_app_date] => 2011-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5829
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20110257227.pdf
[firstpage_image] =>[orig_patent_app_number] => 13172977
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/172977 | Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo Methylphenidate | Jun 29, 2011 | Abandoned |
Array
(
[id] => 7670196
[patent_doc_number] => 20110319465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-29
[patent_title] => 'ESTROGEN RECEPTOR MODULATORS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/165431
[patent_app_country] => US
[patent_app_date] => 2011-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6951
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13165431
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/165431 | Estrogen receptor modulators and uses thereof | Jun 20, 2011 | Issued |
Array
(
[id] => 7491210
[patent_doc_number] => 20110237858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'Device and Methods for Sequential, Regional Delivery of Multiple Cytotoxic Agents and Directed Assembly of Wound Repair Tissues'
[patent_app_type] => utility
[patent_app_number] => 13/117209
[patent_app_country] => US
[patent_app_date] => 2011-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5560
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20110237858.pdf
[firstpage_image] =>[orig_patent_app_number] => 13117209
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/117209 | Device and methods for sequential, regional delivery of multiple cytotoxic agents and directed assembly of wound repair tissues | May 26, 2011 | Issued |
Array
(
[id] => 7670233
[patent_doc_number] => 20110319502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-29
[patent_title] => 'Compositions and Methods for Enhancing Reduction of Spore-Forming Microorganisms'
[patent_app_type] => utility
[patent_app_number] => 13/116100
[patent_app_country] => US
[patent_app_date] => 2011-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12131
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13116100
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/116100 | Compositions and Methods for Enhancing Reduction of Spore-Forming Microorganisms | May 25, 2011 | Abandoned |
Array
(
[id] => 8708575
[patent_doc_number] => 20130065864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'NOVEL IRIDIUM/RHODIUM ANTI-CANCER COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/698965
[patent_app_country] => US
[patent_app_date] => 2011-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 23737
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13698965
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/698965 | Iridium/rhodium anti-cancer compounds | May 19, 2011 | Issued |
Array
(
[id] => 9676948
[patent_doc_number] => 08815858
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-26
[patent_title] => 'Heterocyclic flaviviridae virus inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/699142
[patent_app_country] => US
[patent_app_date] => 2011-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20249
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699142
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/699142 | Heterocyclic flaviviridae virus inhibitors | May 19, 2011 | Issued |
Array
(
[id] => 6088065
[patent_doc_number] => 20110217357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-08
[patent_title] => 'METHOD FOR SOLUBILIZING METRONIDAZOLE'
[patent_app_type] => utility
[patent_app_number] => 13/110116
[patent_app_country] => US
[patent_app_date] => 2011-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4863
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20110217357.pdf
[firstpage_image] =>[orig_patent_app_number] => 13110116
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/110116 | Method for solubilizing metronidazole | May 17, 2011 | Issued |
Array
(
[id] => 7488145
[patent_doc_number] => 20110251279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-13
[patent_title] => 'Composition of Amino Acids for Sublingual Applying for Enhanced Skin Integument Repigmentation in Vitiligo and Method of its Administration'
[patent_app_type] => utility
[patent_app_number] => 13/097045
[patent_app_country] => US
[patent_app_date] => 2011-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1565
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0251/20110251279.pdf
[firstpage_image] =>[orig_patent_app_number] => 13097045
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/097045 | Composition of amino acids for sublingual applying for enhanced skin integument repigmentation in vitiligo and method of its administration | Apr 27, 2011 | Issued |
Array
(
[id] => 6064331
[patent_doc_number] => 20110201611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'Process for the Preparation of Compositions for Modulating a Kinase Cascade and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/094667
[patent_app_country] => US
[patent_app_date] => 2011-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 33527
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20110201611.pdf
[firstpage_image] =>[orig_patent_app_number] => 13094667
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/094667 | Process for the preparation of compositions for modulating a kinase cascade and methods of use thereof | Apr 25, 2011 | Issued |
Array
(
[id] => 6064334
[patent_doc_number] => 20110201612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'Compositions for Modulating a Kinase Cascade and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/094679
[patent_app_country] => US
[patent_app_date] => 2011-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 44713
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20110201612.pdf
[firstpage_image] =>[orig_patent_app_number] => 13094679
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/094679 | Compositions for modulating a kinase cascade and methods of use thereof | Apr 25, 2011 | Issued |
Array
(
[id] => 6113362
[patent_doc_number] => 20110190284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-04
[patent_title] => 'AEROSOL FORMULATIONS FOR THE INHALATION OF BETA-AGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/087009
[patent_app_country] => US
[patent_app_date] => 2011-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11705
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20110190284.pdf
[firstpage_image] =>[orig_patent_app_number] => 13087009
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/087009 | AEROSOL FORMULATIONS FOR THE INHALATION OF BETA-AGONISTS | Apr 13, 2011 | Abandoned |
Array
(
[id] => 5959676
[patent_doc_number] => 20110184063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'Treatment of neurodegenerative conditions'
[patent_app_type] => utility
[patent_app_number] => 13/064647
[patent_app_country] => US
[patent_app_date] => 2011-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8069
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20110184063.pdf
[firstpage_image] =>[orig_patent_app_number] => 13064647
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/064647 | Treatment of neurodegenerative conditions | Apr 5, 2011 | Abandoned |
Array
(
[id] => 8909497
[patent_doc_number] => 08481560
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-09
[patent_title] => 'Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists'
[patent_app_type] => utility
[patent_app_number] => 13/079758
[patent_app_country] => US
[patent_app_date] => 2011-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 22237
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13079758
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/079758 | Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists | Apr 3, 2011 | Issued |